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Radiotherapy is an important treatment modality used for over
half of all patients with cancer and a few benign conditions.
Treatment planning, the design of radiotherapy for each indi-
vidual case, is at the heart of radiotherapy and is thought of as
both a science and an art. Due to the complex physics and
mathematics involved, radiotherapy treatment planning is a
pioneer among computationally supported medical processes.
However, conventional treatment planning is still performed by
humans—highly trained professionals called medical dosime-
trists—using computer tools. The human planner interacts
numerous times in the process of generating a plan with the
treatment-planning system based on experience and skills to
ensure satisfactory quality of each plan.
Like it has recently transformed and disrupted fields such as
computer vision, natural language processing, and automobile
autopiloting, artificial intelligence (AI) has promised to revo-
lutionize radiotherapy treatment planning. In this special col-
lection, we curated a series of articles reporting on the cutting
edge of this important field at an exciting point of time. The
review article of Wang et al1 summarizes the current smart
planning tools in 3 main categories: automated rule implemen-
tation and reasoning (ARIR), modeling of prior knowledge in
clinical practice (KBP), and multicriteria optimization. The
article systematically reviews the development history, clinical
applications, and current progress on these main algorithms.
Other recent progress, as well as emerging directions in AI-
based treatment planning, are also reviewed, such as the appli-
cations of various deep learning algorithms, voxel-based dose
prediction, and reinforcement learning. The challenges of AI in
radiotherapy treatment planning are discussed alongside an
outlook of the necessary requirements in regulation and
collaboration.
As described in this review, one big impact of these AI
algorithms is the potential improvement in the treatment plan-
ning workflow efficiency through automation. With such auto-
mation, human planners can be spared from many manual
processes and therefore afforded more time to focus on further
improving the plan quality. Wang et al’s study2 shows such an
example in which a commercial ARIR algorithm, Pinnacle
AutoPlan, was used to explore the dose-escalation limit of
pancreatic stereotactic body radiotherapy (SBRT). Stereotactic
body radiotherapy is an important treatment modality for bor-
derline resectable and locally advanced pancreatic cancer that
has shown promise but can be limited by normal tissue toxicity.
Individualized target dose escalation within the normal tissue
dose limit is potentially clinically meaningful but usually too
time consuming to be practical. However, with the automation
afforded by AI, this becomes feasible. Another study by Smith
et al3 reports a rigorously designed comparison between 2
widely used commercial treatment-planning automation algo-
rithms on prostate bed planning, including 1 ARIR-based algo-
rithm (Pinnacle AutoPlan) and 1 KBP-based algorithm (Varian
RapidPlan). Although clinicians and researchers are naturally
interested in the performance comparison between these 2 fun-
damentally different algorithms, there has not been a good
comparison reported, especially one that is well designed to
rule out the human factors at play and ensure the comparison
objectivity. The study by Smith et al nicely filled this important
void. Using an established quantitative metric, the 2 algorithms
were compared and found to yield similar performance. Inter-
estingly, on one Plan Challenge case used for a human planner
competition, both automation algorithms were able to achieve
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above-human average performances with marked efficiency
improvement.
Our special collection also reports new applications in
AI-based treatment planning. While conventional algorithms
operate on inverse treatment planning and focus on dose opti-
mization, Wang et al4 report a method to automate and optimize
beam settings that can be followed by automatic fluence optimi-
zation for whole-breast radiotherapy. This typically requires a
medical dosimetrist to spend substantial time on manual forward
planning. In another study, Li et al5 investigate a collimator
setting optimization algorithm for pancreatic SBRT treated with
volumetric-modulated arc therapy (VMAT). This setting in con-
ventional treatment planning is usually not optimized. Using this
new algorithm to explore a new degree of freedom, significantly
better sparing was achieved for organs at risk, important for this
treatment modality.
Articles in this special collection also explore the practical
challenges of current AI algorithms. Landers et al6 report an
interesting study comparing 3 KBP dose prediction algorithms
for both 4p intensity-modulated radiotherapy (IMRT) and
VMAT on a few disease sites including head and neck, lung,
and prostate, each with limited patient data in terms of case
numbers. Their comparisons illustrate an important finding:
When patient data are limited for KBP, simple statistical learn-
ing is more robust to patient variability and hence better at dose
prediction than more sophisticated machine learning methods.
Addressing similar issues, Sheng et al7 propose a case-based
reasoning method by judiciously combining the use of atlas-
based and regression-based prediction to improve a model’s
overall robustness, particularly effective when dealing with
novel anatomy. The applicability of their method was demon-
strated on a cohort of patients having prostate cancer treated
with IMRT.
An important issue in data science is data size—limited data
increase the uncertainty of the data model. This is particularly
critical for AI-based treatment planning because the data size in
treatment planning is smaller than other big data applications in
health care such as imaging. As mentioned earlier, the study of
Landers et al6 highlights this problem and the importance of
proper method selection. In another study conducted by Zhang
et al,8 historical IMRT treatment plans of a large cohort of
patients with head and neck cancer from a single institution
(n ¼ 927) were used to demonstrate the effectiveness of a
knowledge-based statistical inference method for evaluating
plan quality based on similar plans from the database. With
this sufficiently large database, similar historical plans in terms
of both geometry and dosimetry were selected to provide sim-
ple statistical predictions for new plans. This work developed
useful infrastructures for automatic data extraction, anonymi-
zation, and analysis, which could also allow multi-institutional
data integration to further increase data size. On the other hand,
even from single institutional data, the challenges of data het-
erogeneity highlight the importance of proper data homogeni-
zation in data-based methods for AI-based treatment planning.
Finally, fully AI-based treatment planning requires automa-
tion of the entire treatment planning workflow. Artificial
intelligence-based segmentation is, therefore, an important
branch of research as delineating regions of interest (ROIs) is
an important and time-consuming step. The automatic segmen-
tation of ROIs could greatly improve efficiency and possibly
improve consistency. Conventionally, this has been done based
on intensity thresholding, edge detection, and other mathemat-
ical methods. These algorithms mostly work on ROIs distinct
from their backgrounds, such as lung, spinal cord, and brain but
have limited accuracy to be clinically useful for other applica-
tions. With the advent of modern AI, machine learning—espe-
cially deep learning—approaches have demonstrated great
potential in accurate ROI autosegmentation. In this collection,
2 noteworthy works on this topic are included.
In Li et al study,9 a deep learning U-Net model was used to
autosegment the tumor target for nasopharyngeal radiotherapy.
Using a large cohort of 502 patients divided into the training,
validation, and testing data sets, they were able to train an
algorithm to automatically segment the tumor targets in under
a minute and achieve over 70% of agreement in terms of Dice
similarity coefficient for primary tumors and over 60% agree-
ment for involved lymph nodes compared against manual seg-
mentation which takes a few hours to complete. While such
performances are encouraging, it is also important to note that
there remains much room for improvement before AI-based
algorithms could completely replace humans on such challen-
ging tasks. For the task investigated in this study, the remaining
30% to 40% inaccuracy compared to manual segmentation still
takes hours of manual effort, so the semi-autosegmentation
approach combining the AI algorithm and manual touch-up
saved on average less than half an hour on each case compared
to the completely manual approach.
To boost research in this important area, professional soci-
eties such as the Society of Photo-Optical Instrumentation
Engineers, the American Association of Physicists in Medicine,
and the National Cancer Institute have organized open competi-
tions to use AI-based algorithms to solve specific clinical tasks.
Chen et al’s work10 detailed the algorithms they developed for
the Prostate-X Grand Challenge held by the abovementioned 3
organizations. In this challenge, the clinical task was to detect
cancer on multiparametric magnetic resonance images from sus-
picious prostate lesions that included both cancer and benign
lesions. They applied a transfer-learning approach to retune a
deep convolutional neural network algorithm pretrained on Ima-
geNet, a large data set of regular (nonmedical) images, based on
the clinical task. Their best-performing model achieved the third
best score among the 72 models submitted from 33 competing
teams, and the performance was similar to radiologists following
the standard clinical protocol. This work highlights the potential
of using transfer learning to address the data size limitation in the
medical problems and also demonstrates the importance of
proper data processing and rigorous method design.
Artificial intelligence is rapidly propelling many revolution-
ary changes in our lives. Unmanned drones now share the sky
with the piloted aircrafts for various tasks, and self-driving cars
may completely reshape what “learning to drive” means for
today’s preteens. Like these other fields, radiotherapy
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treatment planning also holds tremendous opportunities and
challenges for AI-based automation. We hope the review arti-
cle and the original research articles in this special collection
provide our readers with an overview of current research and a
glimpse of what the future holds.
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